Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the...
8 insider purchases on record · latest filing 2025-03-19.
Insiders have also filed 23 sale transactions at ACHV.